Logo image of MORT

VANECK MORTGAGE REIT INCOME (MORT) Stock Overview

USA - NYSEARCA:MORT - US92189F4524 - ETF

10.39 USD
+0.08 (+0.78%)
Last: 10/17/2025, 8:04:00 PM
Fundamental Rating

6

MORT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. While MORT has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on MORT. These ratings would make MORT suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MORT had positive earnings in the past year.
In the past year MORT had a positive cash flow from operations.
Each year in the past 5 years MORT has been profitable.
Each year in the past 5 years MORT had a positive operating cash flow.
MORT Yearly Net Income VS EBIT VS OCF VS FCFMORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

With an excellent Return On Assets value of 4.39%, MORT belongs to the best of the industry, outperforming 87.65% of the companies in the same industry.
With an excellent Return On Equity value of 8.81%, MORT belongs to the best of the industry, outperforming 86.42% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.17%, MORT belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MORT is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
MORT Yearly ROA, ROE, ROICMORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MORT's Profit Margin of 5.84% is amongst the best of the industry. MORT outperforms 91.36% of its industry peers.
MORT's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 10.65%, MORT belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
MORT's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 27.60%, MORT belongs to the best of the industry, outperforming 83.95% of the companies in the same industry.
In the last couple of years the Gross Margin of MORT has remained more or less at the same level.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
MORT Yearly Profit, Operating, Gross MarginsMORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MORT is creating some value.
The number of shares outstanding for MORT has been reduced compared to 1 year ago.
Compared to 5 years ago, MORT has less shares outstanding
MORT has a worse debt/assets ratio than last year.
MORT Yearly Shares OutstandingMORT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MORT Yearly Total Debt VS Total AssetsMORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.08 indicates that MORT is not a great score, but indicates only limited risk for bankruptcy at the moment.
MORT has a worse Altman-Z score (2.08) than 74.07% of its industry peers.
MORT has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as MORT would need 6.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.05, MORT is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
A Debt/Equity ratio of 0.32 indicates that MORT is not too dependend on debt financing.
MORT has a Debt to Equity ratio of 0.32. This is amongst the best in the industry. MORT outperforms 80.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 2.08
ROIC/WACC1.46
WACC5.58%
MORT Yearly LT Debt VS Equity VS FCFMORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.80 indicates that MORT should not have too much problems paying its short term obligations.
MORT's Current ratio of 1.80 is fine compared to the rest of the industry. MORT outperforms 69.14% of its industry peers.
A Quick Ratio of 1.12 indicates that MORT should not have too much problems paying its short term obligations.
MORT has a Quick ratio of 1.12. This is in the better half of the industry: MORT outperforms 67.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
MORT Yearly Current Assets VS Current LiabilitesMORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The earnings per share for MORT have decreased strongly by -18.28% in the last year.
The Earnings Per Share has been growing slightly by 1.64% on average over the past years.
MORT shows a decrease in Revenue. In the last year, the revenue decreased by -3.62%.
Measured over the past years, MORT shows a small growth in Revenue. The Revenue has been growing by 2.41% on average per year.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

Based on estimates for the next years, MORT will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.63% on average per year.
The Revenue is expected to grow by 2.47% on average over the next years.
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue Next Year-2%
Revenue Next 2Y0.2%
Revenue Next 3Y1.31%
Revenue Next 5Y2.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MORT Yearly Revenue VS EstimatesMORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
MORT Yearly EPS VS EstimatesMORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

9

4. Valuation

4.1 Price/Earnings Ratio

MORT is valuated cheaply with a Price/Earnings ratio of 4.07.
Based on the Price/Earnings ratio, MORT is valued cheaply inside the industry as 98.77% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of MORT to the average of the S&P500 Index (27.40), we can say MORT is valued rather cheaply.
A Price/Forward Earnings ratio of 2.43 indicates a rather cheap valuation of MORT.
Based on the Price/Forward Earnings ratio, MORT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.94. MORT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.07
Fwd PE 2.43
MORT Price Earnings VS Forward Price EarningsMORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MORT indicates a rather cheap valuation: MORT is cheaper than 98.77% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MORT indicates a rather cheap valuation: MORT is cheaper than 96.30% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.08
EV/EBITDA 2.03
MORT Per share dataMORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MORT has an outstanding profitability rating, which may justify a higher PE ratio.
MORT's earnings are expected to grow with 15.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)2.48
EPS Next 2Y18.35%
EPS Next 3Y15.63%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.65%, MORT is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.15, MORT has a dividend in line with its industry peers.
MORT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.65%

5.2 History

The dividend of MORT is nicely growing with an annual growth rate of 7.84%!
MORT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.84%
Div Incr Years0
Div Non Decr Years0
MORT Yearly Dividends per shareMORT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

MORT pays out 62.40% of its income as dividend. This is not a sustainable payout ratio.
MORT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
MORT Yearly Income VS Free CF VS DividendMORT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
MORT Dividend Payout.MORT Dividend Payout, showing the Payout Ratio.MORT Dividend Payout.PayoutRetained Earnings

VANECK MORTGAGE REIT INCOME

NYSEARCA:MORT (10/17/2025, 8:04:00 PM)

10.39

+0.08 (+0.78%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners46.28%
Inst Owner Change0.23%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap7.33B
Analysts80
Price Target13.14 (26.47%)
Short Float %0.11%
Short Ratio1.34
Dividend
Industry RankSector Rank
Dividend Yield 4.65%
Yearly Dividend1.56
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years0
Div Non Decr Years0
Ex-Date10-01 2025-10-01 (0.363)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.35%
PT rev (3m)14.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.32%
EPS NY rev (3m)-10.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-2.81%
Valuation
Industry RankSector Rank
PE 4.07
Fwd PE 2.43
P/S 0.24
P/FCF 5.08
P/OCF 1.86
P/B 0.36
P/tB 0.48
EV/EBITDA 2.03
EPS(TTM)2.55
EY24.54%
EPS(NY)4.27
Fwd EY41.14%
FCF(TTM)2.05
FCFY19.7%
OCF(TTM)5.58
OCFY53.74%
SpS44.14
BVpS29.25
TBVpS21.53
PEG (NY)0.19
PEG (5Y)2.48
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 2.08
F-Score5
WACC5.58%
ROIC/WACC1.46
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-2%
Revenue Next 2Y0.2%
Revenue Next 3Y1.31%
Revenue Next 5Y2.47%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year59.12%
EBIT Next 3Y22.78%
EBIT Next 5Y17.41%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%